Keywords: Hyperpolarized MR (Non-Gas), Hyperpolarized MR (Non-Gas), Hyperpolarized MR (Non‐Gas), Multi‐Contrast, kidney, urogenital, cronic kidney disease, autosomal dominant polycystic kidney disease
Motivation: Metabolic features of autosomal-dominant-polycystic-kidney-disease (ADPKD) and chronic kidney disease (CKD) are not fully understood and cannot be examined with current clinical tools. It may be possible with Hyperpolarized [1-13C]pyruvate (HP 13C) MRI.
Goal(s): To evaluate HP 13C MR images including metabolic profiles in both ADPKD- and CKD-patients compared with healthy controls.
Approach: Presenting the preliminary results of initial participants included in the ongoing clinical trial entitled “Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI”.
Results: Initial evaluation of results might indicate metabolic profiles as biomarkers in disease progression in ADPKD patients.
Impact: The metabolic signatures and images obtained from HP 13C MR may help monitoring disease progression in autosomal-dominant-polycystic-kidney-disease (ADPKD) and chronic kidney disease (CKD) and increase knowledge of pathological elements in these diseases.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords